Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species

被引:224
|
作者
Coskran, Timothy M.
Morton, Daniel
Menniti, Frank S.
Adamowicz, Wendy O.
Kleiman, Robin J.
Ryan, Anne M.
Strick, Christine A.
Schmidt, Christopher J.
Stephenson, Diane T.
机构
[1] PGRD Groton, Dept Safety Sci, Groton, CT 06340 USA
[2] PGRD Groton, Dept CNS Discovery, Groton, CT 06340 USA
关键词
phosphodiesterase; 10A; immunohistochemistry; localization; striatum; testis; enteric ganglia; nuclear;
D O I
10.1369/JHC.6A6930.2006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A monoclonal antibody directed against the amino terminal of rat phosphodiesterase 10A (PDE10A) was used to localize PDE10A in multiple central nervous system (CNS) and peripheral tissues from mouse, rat, dog, cynomolgus macaque, and human. PDE10A immunoreactivity is strongly expressed in the CNS of these species with limited expression in peripheral tissues. Within the brain, strong immunoreactivity is present in both neuronal cell bodies and neuropil of the striatum, in striatonigral and striatopallidal white matter tracks, and in the substantia nigra and globus pallidus. Outside the brain, PDE10A immunoreactivity is less intense, and distribution is limited to few tissues such as the testis, epididymal sperm, and enteric ganglia. These data demonstrate that PDE10A is an evolutionarily conserved phosphodiesterase highly expressed in the brain but with restricted distribution in the periphery in multiple mammalian species.
引用
收藏
页码:1205 / 1213
页数:9
相关论文
共 50 条
  • [21] Phosphodiesterase 10A in the Rat Pineal Gland: Localization, Daily and Seasonal Regulation of Expression and Influence on Signal Transduction
    Spiwoks-Becker, Isabella
    Wolloscheck, Tanja
    Rickes, Oliver
    Kelleher, Debra K.
    Rohleder, Nils
    Weyer, Veronika
    Spessert, Rainer
    NEUROENDOCRINOLOGY, 2011, 94 (02) : 113 - 123
  • [22] Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
    Raheem, Izzat T.
    Breslin, Michael J.
    Fandozzi, Christine
    Fuerst, Joy
    Hill, Nicole
    Huszar, Sarah
    Kandebo, Monika
    Kim, Somang H.
    Ma, Bennett
    McGaughey, Georgia
    Renger, John J.
    Schreier, John D.
    Sharma, Sujata
    Smith, Sean
    Uslaner, Jason
    Yan, Youwei
    Coleman, Paul J.
    Cox, Christopher D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (18) : 5903 - 5908
  • [23] Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
    Raheem, Izzat T.
    Schreier, John D.
    Fuerst, Joy
    Gantert, Liza
    Hostetler, Eric D.
    Huszar, Sarah
    Joshi, Aniket
    Kandebo, Monika
    Kim, Somang H.
    Li, Jing
    Ma, Bennett
    McGaughey, Georgia
    Sharma, Sujata
    Shipe, William D.
    Uslaner, Jason
    Vandeveer, George H.
    Yan, Youwei
    Renger, John J.
    Smith, Sean M.
    Coleman, Paul J.
    Cox, Christopher D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (01) : 126 - 132
  • [24] Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors
    Kehler, Jan
    Ritzen, Andreas
    Langgard, Morten
    Petersen, Sebastian Leth
    Farah, Mohamed M.
    Bundgaard, Christoffer
    Christoffersen, Claus Tornby
    Nielsen, Jacob
    Kilburn, John Paul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3738 - 3742
  • [25] Brain phosphodiesterase 10A occupancy measured by PET after oral administration of TAK-063, a newly developed phosphodiesterase 10A inhibitor, in human volunteers
    Takano, A.
    Stenkrona, P.
    Stepanov, V.
    Amini, N.
    Martinsson, S.
    Tsai, M.
    Goldsmith, P.
    Wu, J.
    Xie, J.
    Uz, T.
    Macek, T.
    Halldin, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S316 - S316
  • [26] Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A
    Zhang, Zhanbin
    Lu, Xiaoxia
    Xu, Jinbin
    Rothfuss, Justin
    Mach, Robert H.
    Tu, Zhude
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 3986 - 3995
  • [27] Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors
    Geneste, Herve
    Drescher, Karla
    Jakob, Clarissa
    Laplanche, Loic
    Ochse, Michael
    Torrent, Maricel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (03) : 406 - 412
  • [28] Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors
    Malamas, Michael S.
    Ni, Yike
    Erdei, James
    Stange, Hans
    Schindler, Rudolf
    Lankau, Hans-Joachim
    Grunwald, Christian
    Fan, Kristi Yi
    Parris, Kevin
    Langen, Barbara
    Egerland, Ute
    Hage, Thorsten
    Marquis, Karen L.
    Grauer, Steve
    Brennan, Julie
    Navarra, Rachel
    Graf, Radka
    Harrison, Boyd L.
    Robichaud, Albert
    Kronbach, Thomas
    Pangalos, Menelas N.
    Hoefgen, Norbert
    Brandon, Nicholas J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) : 7621 - 7638
  • [29] Phosphodiesterase 10A inhibitors: a 2009-2012 patent update
    Kehler, Jan
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (01) : 31 - 45
  • [30] Targeting phosphodiesterase 10A for chemoprevention and treatment of ovarian cancer.
    da Silva, Luciana Madeira
    Gavin, Elaine
    Lee, Kevin
    Aragon, Ileana
    Ramirez-Alcantara, Veronica
    Scalici, Jennifer
    Rocconi, Rodney P.
    Piazza, Gary A.
    CLINICAL CANCER RESEARCH, 2016, 22